Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,917Revenue $M492Net Margin (%)-6.1Altman Z-Score4.3
Enterprise Value $M5,866EPS $-0.1Operating Margin %-20.0Piotroski F-Score7
P/E(ttm)--Beneish M-Score2.0Pre-tax Margin (%)-28.1Higher ROA y-yY
Price/Book3.010-y EBITDA Growth Rate %11.0Quick Ratio1.6Cash flow > EarningsY
Price/Sales10.85-y EBITDA Growth Rate %49.2Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow31.0y-y EBITDA Growth Rate %--ROA % (ttm)-1.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-2.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M546ROIC % (ttm)-9.3Gross Margin Increase y-yY

Gurus Latest Trades with OPK

Number of guru portfolios checked: 68.
TickerupGuruDate Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OPKKen Fisher 2016-03-31 Add$7.66 - $11.6
($9.12)
$ 10.8419%Add 0.11%37,867
OPKGeorge Soros 2015-12-31 Buy 0.01%$8.51 - $11.28
($10.07)
$ 10.848%New holding55,500
OPKJoel Greenblatt 2015-12-31 Buy 0.01%$8.51 - $11.28
($10.07)
$ 10.848%New holding120,369
OPKMario Gabelli 2015-12-31 Reduce$8.51 - $11.28
($10.07)
$ 10.848%Reduce -14.79%144,775
OPKKen Fisher 2015-12-31 Add$8.51 - $11.28
($10.05)
$ 10.848%Add 6.55%37,826
OPKGeorge Soros 2015-09-30 Sold Out -0.04%$8.41 - $17.21
($13.29)
$ 10.84-18%Sold Out0
OPKJoel Greenblatt 2015-09-30 Sold Out -0.01%$8.41 - $17.21
($13.29)
$ 10.84-18%Sold Out0
OPKMario Gabelli 2015-09-30 Add0.01%$8.41 - $17.21
($13.29)
$ 10.84-18%Add 1599.00%169,900
OPKKen Fisher 2015-09-30 Add$8.41 - $17.21
($13.29)
$ 10.84-18%Add 21.58%35,500
OPKJoel Greenblatt 2015-06-30 Buy 0.01%$13.76 - $19.12
($15.53)
$ 10.84-30%New holding42,947
OPKMario Gabelli 2015-06-30 Reduce$13.76 - $19.12
($15.53)
$ 10.84-30%Reduce -9.09%10,000
OPKKen Fisher 2015-03-31 Buy $9.91 - $15.03
($13.01)
$ 10.84-17%New holding29,200
OPKMario Gabelli 2014-09-30 Reduce$8.19 - $9.46
($8.79)
$ 10.8423%Reduce -26.67%11,000
OPKGeorge Soros 2014-06-30 Reduce-0.12%$8.01 - $9.71
($8.73)
$ 10.8424%Reduce -84.24%235,600
OPKGeorge Soros 2014-03-31 Add0.06%$7.58 - $9.96
($8.75)
$ 10.8424%Add 76.98%1,494,800
OPKGeorge Soros 2013-09-30 Buy 0.07%$7.18 - $9.24
($8.02)
$ 10.8435%New holding745,000
OPKMario Gabelli 2011-03-31 Reduce$3.48 - $4.83
($4.01)
$ 10.84170%Reduce -90.58%15,000
OPKMario Gabelli 2010-09-30 Add$2.07 - $2.6
($2.31)
$ 10.84369%Add 962.00%159,300
OPKMario Gabelli 2010-06-30 Reduce$1.87 - $2.55
($2.11)
$ 10.84414%Reduce -90.00%15,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OPK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


OPK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-04-27Buy11,800$10.951.19view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-04-25Buy15,000$11.12-0.36view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-04-19Buy7,400$110.73view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-04-15Buy7,600$10.782.78view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-04-06Buy20,000$10.614.43view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-04-05Buy20,000$10.287.78view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-04-01Buy23,600$10.357.05view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-03-31Buy25,000$10.267.99view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-03-30Buy85,600$10.19.7view
Rubin Steven DExecutive VP-Administration 2016-03-30Buy1,000$10.178.95view

Press Releases about OPK :

Quarterly/Annual Reports about OPK:

News about OPK:

Articles On GuruFocus.com
Weekly CEO Buys Highlights Mar 14 2016 
Weekly CEO Buys Highlights Jan 26 2016 
Weekly CEO Buys Highlight: FS Investment, Opko, Ambac, Calamos, Praxair Jan 11 2016 
Weekly CEO Buys Highlights for the Final Week of 2015 Jan 04 2016 
Weekly CEO Buys Highlight: Prospect Capital, Sears Holdings, Calamos Asset Management, Opko Health, Dec 28 2015 
Weekly CEO Buys Highlight: GHL, OPK, DKL, ATI, PEB Nov 02 2015 
Weekly CEO Buys Highlight: Box, Opko, Neonode, FS Investment, Celator Pharmaceuticals Oct 16 2015 
Weekly CEO Buys Highlight: CC, OPK, PX, PSG, JOY Sep 12 2015 
Weekly CEO Buys Highlight: Shutterstock, Endurance Specialty Holdings, Opko, Air Products, KapStone Aug 31 2015 
Top Insider Buys of the Week Aug 28 2015 

More From Other Websites
OPKO Offers Additional Data On RAYALDEE At National Kidney Foundation Spring Clinical Meetings Apr 28 2016
8:32 am Opko Health presents additional data on Rayaldee at National Kidney Foundation Spring... Apr 28 2016
OPKO Presents Additional Data on RAYALDEE® at National Kidney Foundation Spring Clinical Meetings... Apr 28 2016
Insiders Are Scooping Up These 5 Stocks Apr 27 2016
OPKO Health Says FDA Accepts Resubmission Of NDA For Its RAYALDEE Apr 27 2016
FDA Accepts Resubmission of New Drug Application for RAYALDEE® Apr 27 2016
FDA Accepts Resubmission of New Drug Application for RAYALDEE® Apr 27 2016
OPKO Health Appoints James DeMarco As SVP Of Pharmaceutical Sales Apr 25 2016
OPKO Announces Appointment of James DeMarco as Senior Vice President of Pharmaceutical Sales Apr 25 2016
OPKO Announces Appointment of James DeMarco as Senior Vice President of Pharmaceutical Sales Apr 25 2016
Cocrystal Pharma Receives Health Canada Approval to Conduct Phase I Clinical Study for CC-31244 in... Apr 25 2016
Cocrystal Pharma Receives Health Canada Approval to Conduct Phase I Clinical Study for CC-31244 in... Apr 25 2016
5 Toxic Stocks to Get Rid Of Now Apr 22 2016
Weekly Biotech Report Covering Opko Health Inc (NYSE:OPK) Intercept Pharmaceuticals (NASDAQ:ICPT)... Apr 11 2016
This Company Just Inked A Deal Contingent On Generating Earnings Per Share Apr 08 2016
5 Stocks Insiders Love Right Now Apr 06 2016
OPKO HEALTH, INC. Files SEC form 8-K, Other Events Apr 06 2016
Top 6 Biopharma Movers of the Past Week Apr 03 2016
OPKO HEALTH, INC. Files SEC form 8-K, Change in Directors or Principal Officers Apr 01 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)